{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT02545504: Phase 3 Interventional Completed Gastric Adenocarcinoma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02239211: Phase 2 Interventional Completed Primary Sclerosing Cholangitis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pemziviptadil [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efpegsomatropin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01439971: Phase 1 Interventional Completed Hemophilia A
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02202759: Phase 2 Interventional Terminated Adenocarcinoma of the Stomach
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:exbivirumab [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
NCT02226146: Phase 2 Interventional Completed Pemphigoid, Bullous
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02785900: Phase 3 Interventional Terminated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
PROTEIN
